Secondary Prevention and Recidivism Reduction in Trauma Patients

Trauma Clinical Trial

Official title:

Secondary Prevention and Recidivism Reduction in Trauma Patients

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT03967262
• Other study ID #: CSPT-CG-PPT2
• Status: Not yet recruiting
• Phase: N/A
• Start date: September 1, 2020
• Est. completion date: October 1, 2022

Study information

• Verified date: January 2020
• Source: Corporacion Parc Tauli
• Contact: Oriol Pino-Perez, MD
• Phone: +34676607948
• Email: oriol.pino[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The consumption of alcohol and other drugs is one of the main risk factors for traumatism. In addition, patients who have suffered an accident in relation to the consumption of these substances present a high risk of recidivism. In the case of alcohol, its relationship with traumatisms has been known for many years now and is still one of the main risk factors.

Secondary prevention is an important area of action and improvement in the treatment of this type of patient by considering actions, such as a brief motivational intervention, in order to avoid recidivism. The objective of motivational intervention is to make the patient aware of the relationship between the consumption of these substances and the accident, and induce them to carry out a change in habits.

The objective of the present investigation project is to determine the efficacy of secondary prevention in reducing recurrence of traumatisms. In order to this, a multicenter randomised controlled trial has been designed in which the intervention group with patients admitted for sever traumatism with positive screening for alcohol or other drugs, will be submitted to a brief motivational intervention. The main outcome will be trauma recurrence within a three year follow-up.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 102
• Est. completion date: October 1, 2022
• Est. primary completion date: October 1, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Sever trauma patients defined as the need of assistance in a critical unit.

• Positive screening for alcohol o other drugs (cannabis, cocaine, methamphetamine).

Exclusion Criteria:

• Patients in treatment for abuse of alcohol and other drugs.

• Death during hospitalization.

• Non Catalonia residents.

• Not Spanish or Catalan spoken.

Related Conditions & MeSH terms

• Alcohol Use, Unspecified
• Drug Use
• Trauma
• Wounds and Injuries

Intervention

Behavioral:
• Brief Motivational Intervention
The objective of motivational intervention is to make the patient aware of the relationship between the consumption of alcohol and other drugs and the accident, and induce them to carry out a change in habits.

Locations

Country	Name	City	State
Spain	Corporacion Sanitaria Parc Taulí	Sabadell	Barcelona

Sponsors (1)

Lead Sponsor	Collaborator
Corporacion Parc Tauli

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Recurrence of traumatisms	Any medical assistance related to a traumatism	Follow-up of 3 years
Secondary	Alcohol prevalence	Alcohol prevalence among trauma patients	Trough study completion, an average of 2 years
Secondary	Other drugs prevalence (cannabis, cocaine, methamphetamine)	Other drugs prevalence among trauma patients	Trough study completion, an average of 2 years
Secondary	Time to a recurrence	Time since discharge until the first new trauma or withdrawal from follow-up.	Trough study completion, an average of 2 years